Bosulif 500 mg film-coated tablets, Olverembatinib, Bosulif 100 mg film-coated tablets
HQP1351CG301
Phase 3 small_molecule active
Quick answer
Bosulif 500 mg film-coated tablets, Olverembatinib, Bosulif 100 mg film-coated tablets for Chronic Phase Chronic Myeloid Leukemia is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Chronic Phase Chronic Myeloid Leukemia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active